Pharmaceutical Executive Digest:
Having trouble viewing this e-mail? Click here.
Share with a colleague
Pharmaceutical Executive Europe  E-News
 
 
 
 
 

You can now follow us on Twitter at Twitter.com/pharmexecutive
 
Survey
Which tools are having the most significant effect in thwarting counterfeit drugs?
Packaging and labeling authentication 76%
Unique drug-product design or authentication printed directly on a solid-dosage product 8%
Social media and improved consumer education 11%
Increased regulation and enforcement 5%

Talk to us:
jupton@advanstar.com

Advertise with us:
Dtaylor-higgins@advanstar.com

27 September, 2013
Building a Rare Diseases Business Model
What are the current obstacles to be overcome and the opportunities to be had in rare disease treatment development and commercialization. Nathan J. Dowden reports ...Read more
Personalization — the Holy Grail of Digital Marketing
It’s not just patients that have interesting marketing ‘personas’ — HCPs have them too.  But how do you make sense of their ‘digital behaviour’? Peter Houston reports ... Read more
Healthcare: the Promise of Predictive Analytics
At Duke University’s Technology and Healthcare Conference, Eric Siegel, founder of Predictive Analytics World, called new predictive analytical tools “inevitable” disruptions to the way physicians make treatment decisions and patients receive care ... Read more
Mobile Solutions to ‘Glocalizing’ in Emerging Markets
How cloud-based mobile and IT solutions can help tackle operational challenges in the emerging markets ... Read more
Pharm Exec Global Digest — Rare and Orphan Diseases Special
In the new issue: Build a rare diseases strategy; Europe’s orphan drug dilemma; Specialty drugs — what to do?; The Smartwatch — why it must embrace digital health; and more ... Read more
Product Profile
Sciformix
Product labeling– Increasing efficiency, enhancing quality, and delivering compliance
Pharmaceutical product labeling is a highly regulated and complex process. A product label is very specific in its content, with respect to safety data, adverse effects and compliance to country specific regulations. Read more
Also in this issue
UK: The Importance of Continued R&D Investment
On the Move: Latest Pharma Appointments
Events